和前独联体地区，公司将加快推进本土化生产项目落地，并探索 新的、稳定的原材料采购渠道，不断建立战略优势。同时，公司将 借助 Agus Fertilizer Conference、IFA Annual Conference 2024、 AGRITECHNICA 、 CRU Phosphates 2024 Conference ＆ Exhibition、ANNA 等国际化展会，不断对公司产品与项目进行宣 传，提高公司曝光度与知名度。感谢您的关注，祝您投资愉快！ 2、随着农业现代化的推进，富邦股份在高效、环保型化肥和化工 原料的研发和生产上有哪些新的计划和策略？ 证券代码：300387 证券简称：富邦股份 湖北富邦科技股份有限公司投资者关系活动记录表 编号：2024-001 | 投资者关系活 | □特定对象调研 □ 分析师会议 | | --- | --- | | 动类别 | □ 媒体采访 √ 业绩说明会 | | | 新闻发布会 路演活动 □ □ | | | 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称 | 通过全景网路演互动平台参加公司 2023 年度网上业绩说明会的 | | 及 ...

湖北富邦科技股份有限公司全体股东： 我们接受委托，在审计了湖北富邦科技股份有限公司（以下简称"富邦股份"）2023 年 12 月 31 日合并及公司的资产负债表，2023 年度合并及公司的利润表、合并及公司的现金流 量表和合并及公司的股东权益变动表以及财务报表附注的基础上，对后附的《上市公司 2023 年度非经营性资金占用及其他关联资金往来的情况汇总表》（以下简称"汇总表"）进行了专 项审核。按照中国证券监督管理委员会印发的《上市公司监管指引第 8 号——上市公司资金 往来、对外担保的监管要求》的规定，编制和披露汇总表、提供真实、合法、完整的审核证 据是富邦股份管理层的责任，我们的责任是在执行审核工作的基础上对汇总表发表专项审核 意见。 我们按照中国注册会计师审计准则的相关规定执行了审核工作。中国注册会计师审计准 则要求我们遵守中国注册会计师职业道德守则，计划和执行审核工作以对汇总表是否不存在 重大错报获取合理保证。在审核过程中，我们实施了包括检查会计记录、重新计算相关项目 金额等我们认为必要的程序。我们相信，我们的审核工作为发表审核意见提供了合理的基础。 我们认为，后附汇总表所载资料与我们审计富邦股份 20 ...

| 报告说明 | | --- | | C 一、公司概况 . | | (一) 公司简介 . | | (二)企业文化… | | (三) 企业荣誉 . | | (四)经营业绩 | | 二、环境保护与可持续发展 . | | (一)把握行业转型升级机遇，加速助剂产品绿色创新 …………………7 | | (二)增值肥料、土壤改良产品，助力土壤耕地保护 . | | (三)生物农业迎来政策利好,践行绿色环保责任. | | (四)数字农业加速落地,健全智慧种植体系 | | (五) 加快办公生产数字化,贯彻低碳理念 | | (0) 三、社会责任与社会公益. | | (一) 股东权益保护 . | | (二) 以人为本, 心系员工 . | | (三)与客户互利共赢 | | (四)社会公益 | | O 四、公司治理与合规运作 | | (一) 依法经营 | | (二) 股东回报保持稳健 | | (三) 健全公司治理体系 | | (四) 做好内幕信息管理 . | | (五) 合法合规信息披露 . | | (六)构建和谐投资者关系……………………………………………………………………………………………………………32 | | ● 五、未来展望 ...

湖北富邦科技股份有限公司 董事会审计委员会对会计师事务所 2023 年度 履行监督职责情况报告 公司于2023年4月16日召开第三届董事会审计委员会2023年第二次会议， 2023 年 4 月 26 日召开第三届董事会第二十六次会议，2023 年 5 月 19 日召开 2022 年年度股东大会同意续聘中审众环为公司 2023 年度审计机构，聘期一年。 二、2023 年年审会计师事务所履职情况 中审众环《审计业务约定书》，遵照《中国注册会计师审计准则》和其他职 业规范，中审众环对公司 2023 年度财务报告及 2023 年 12 月 31 日的财务报告内 部控制有效性进行了审计并出具了专项报告。在本年度审计工作过程中，中审众 环运用职业判断，并保持执业怀疑，并就与财务报表和内部控制审计相关的责任、 计划的审计范围和时间安排的总体情况与治理层进行了沟通。 经审计，中审众环认为公司在所有重大方面按照企业会计准则的规定编制， 公允反映了公司 2023 年 12 月 31 日的合并及公司利润表、合并及公司现金流量 表、合并及公司股东权益变动表以及相关财务报表附注；公司按照《企业内部控 制基本规范》和相关规定在所有方面保 ...

内部控制鉴证报告 众环专字（2024）0100544 号 湖北富邦科技股份有限公司全体股东： 我们接受委托，审核了湖北富邦科技股份有限公司（以下简称"富邦股份"）管理层对 2023 年 12 月 31 日与财务报表相关的内部控制有效性的认定。富邦股份管理层的责任是建 立健全内部控制并保持其有效性，同时对 2023 年 12 月 31 日与财务报表相关的内部控制有 效性作出认定并确保该认定的真实性和完整性。我们的责任是对富邦股份截至 2023 年 12 月 31 日止与财务报表相关的内部控制的有效性发表鉴证意见。 我们按照《中国注册会计师其他鉴证业务准则第3101号——历史财务信息审计或审阅以 外的鉴证业务》并参照《内部控制审核指导意见》的规定执行了鉴证业务。上述规定要求我 们计划和执行鉴证工作，以对鉴证对象信息是否不存在重大错报获取合理保证。在鉴证过程 中，我们实施了包括了解、测试和评价内部控制系统的建立和实施情况，以及我们认为必要 的其他程序。我们相信，我们的鉴证工作为发表意见提供了合理的基础。 内部控制具有固有限制，存在由于错误或舞弊导致错报发生和未被发现的可能性。此外， 由于情况的变化可能导致内部控制变 ...

湖北富邦科技股份有限公司 2023 年度内部控制自我评价报告 湖北富邦科技股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以 下简称"企业内部控制规范体系"），结合湖北富邦科技股份有限公司（以下简称"公 司"）内部控制制度和评价办法，在内部控制日常监督和专项监督的基础上，我们对公 司 2023 年 12 月 31 日（以下简称"内部控制评价报告基准日"）的内部控制有效性进 行了评价。 一、重要声明 根据企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性， 并如实披露内部控制自我评价报告是公司董事会的责任。监事会对董事会建立和实施内 部控制进行监督。经理层负责组织领导企业内部控制的日常运行。 公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假 记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连 带法律责任。 根据公司非财务报告内部控制重大缺陷认定情况，于内部控制评价报告基准日，公 司未发现非财务报告内部控制重大缺陷。 公司自内部控制评价报告基准日至内部控制评价报告披露日之间未发生影响内部 控制有效性评 ...

湖北富邦科技股份有限公司 关于 2023 年度募集资金存放与实际使用情况的专项报告 湖北富邦科技股份有限公司 董事会关于 2023 年度募集资金存放与使用 情况的专项报告 根据中国证监会发布的《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》（2022 年修订）和深圳证券交易所发布的《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》等有关规定，湖北富邦科技股份有限公司（以下简 称"公司"或"本公司"）董事会编制了截至 2023 年 12 月 31 日止募集资金存放与实际使用 情况的专项报告。 一、募集资金基本情况 经中国证券监督管理委员会于 2018 年 1 月 22 日证监许可 [2018] 44 号文核准，本公司 以 2017 年度权益分派实施完毕后总股本 224,870,098 股为基数测算，按每 10 股配售 3 股的 比例向全体股东配售，拟向原股东配售 67,461,029 股人民币普通股 A 股，本次配股发行价 格为人民币 4.43 元/股，截止 2018 年 6 月 29 日，公司已配售人民币普通股 A 股 66,387,997 股，募集资金总额人 ...

湖北富邦科技股份有限公司 关于 2023 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 湖北富邦科技股份有限公司（以下简称"公司"）于 2024 年 4 月 17 日召开 了第四届董事会第七次会议与第四届监事会第六次会议，分别审议通过了《2023 年度利润分配预案》。本议案尚需提交公司股东大会审议，现将有关情况公告如 下： 一、利润分配预案基本情况 根据中审众环会计师事务所（特殊普通合伙）出具的 2023 年度《审计报告》 （众环审字（2024）0101617 号），公司 2023 年度合并报表归属于母公司的净利 润为人民币 71,548,067.23 元，其中母公司的净利润为人民币 5,800,129.41 元，根 据《中华人民共和国公司法》（以下简称"《公司法》"）及《湖北富邦科技股 份有限公司章程》（以下简称"《公司章程》"）的相关规定，按母公司净利润 的 10%提取法定盈余公积金人民币 580,012.94 元后，减去 2022 年度现金分红 14,452,850.90 元，加上合并报表年初未分配利润 579,783,756.92 ...

Financial Performance - The cash received from sales and services increased by 12.44% to ¥290.13 million compared to ¥258.03 million in the same period last year[7]. - The company's operating revenue for Q1 2024 was CNY 315,727,870.21, representing a 27.84% increase compared to CNY 246,970,635.49 in the same period last year[33]. - Net profit attributable to shareholders was CNY 26,200,443.33, up 37.74% from CNY 19,021,304.50 year-over-year[33]. - The net profit after deducting non-recurring gains and losses was CNY 24,985,469.20, reflecting a 40.55% increase from CNY 17,776,709.47 in the previous year[33]. - The net profit for the current period is CNY 27,150,657.98, an increase from CNY 18,271,887.14 in the previous period, representing a growth of approximately 48.5%[69]. - Operating profit for the current period is CNY 36,518,746.27, compared to CNY 24,134,897.18 in the previous period, indicating a growth of about 51.3%[69]. Cash Flow - The net cash flow from operating activities decreased by 112.80% to -¥1.98 million, down from ¥15.48 million in the previous year, primarily due to increased payments to suppliers and employees[7]. - The net cash flow from operating activities was negative at CNY -1,981,641.03, a decline of 112.80% compared to CNY 15,477,002.35 in the same period last year[33]. - Cash flow from operating activities showed a net outflow of CNY 1,981,641.03, a decline from a net inflow of CNY 15,477,002.35 in the previous period[71]. - Cash inflow from investment activities totaled CNY 85,212,438.09, significantly higher than CNY 25,040,792.95 in the previous period[71]. - The net cash outflow from investment activities was CNY 32,716,224.37, an improvement compared to CNY 54,493,900.64 in the previous period[71]. - The company reported a cash and cash equivalents balance of CNY 253,894,274.56 at the end of the period, up from CNY 239,818,757.74 in the previous period[71]. Investment Activities - Cash received from investment recoveries surged by 240.00% to ¥85.00 million, compared to ¥25.00 million in the same period last year, mainly due to the redemption of financial products[7]. - Investment cash payments rose by 48.41% to ¥111.31 million from ¥75.00 million, attributed to payments for the acquisition of a 15% stake in Holland Novochem B.V.[7]. - The company completed the acquisition of a 15% stake in Holland Novochem B.V., increasing its ownership to 100%[21]. Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 1,882,460,741.83, a decrease of 2.95% from CNY 1,939,726,122.82 at the end of the previous year[33]. - Total liabilities decreased to ¥500,103,586.65 from ¥567,842,096.50, a reduction of approximately 11.9%[49]. - Total equity increased to ¥1,382,357,155.18 from ¥1,371,884,026.32, reflecting a growth of about 0.6%[49]. - The company's financial assets decreased by 100.00% due to the redemption of purchased financial products, dropping from ¥1,005.96 million[17]. - Other current liabilities decreased by 67.08% to ¥33.76 million from ¥102.57 million, mainly due to payments related to the equity acquisition[17]. Expenses - Research and development expenses increased by 71.59% to CNY 1,080.56 million, primarily due to increased material costs for new business development[35]. - The company incurred sales expenses of CNY 12,228,075.71, up from CNY 9,090,228.00, marking an increase of approximately 34.5%[69]. - The company's tax expenses rose to CNY 1,228,170.44 from CNY 696,155.51, reflecting an increase of about 76.5%[69]. Market Strategy and Outlook - The company plans to expand its market presence in Africa and Southeast Asia, contributing to the revenue growth observed in the reporting period[35]. - Future outlook includes continued investment in new product development and technology advancements to drive growth[50]. - The company is exploring potential mergers and acquisitions to enhance its competitive position in the market[50]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,448[8]. - Basic and diluted earnings per share for the quarter were both ¥0.0906, an increase from ¥0.0658 in the same period last year[51]. - Net comprehensive income attributable to the parent company was ¥9,578,274.41, compared to ¥25,002,170.93 in the previous year, indicating a significant decrease[51].

Financial Performance - Hubei Forbon Technology Co., Ltd. reported a net profit of CNY 55 million for the fiscal year 2023, representing a year-on-year increase of 21%[111]. - The company achieved a revenue of CNY 300 million in 2023, reflecting a growth of 15% compared to the previous year[111]. - The company's operating revenue for 2023 reached ¥1,048,531,572.70, representing a 23.72% increase compared to ¥847,519,792.90 in 2022[127]. - The net profit attributable to shareholders for 2023 was ¥71,548,067.23, up 32.86% from ¥53,851,228.64 in 2022[127]. - The net cash flow from operating activities significantly increased by 227.47% to ¥102,009,640.04 in 2023, compared to ¥31,150,630.72 in 2022[127]. - The basic earnings per share for 2023 was ¥0.25, a 31.58% increase from ¥0.19 in 2022[127]. - Total assets at the end of 2023 amounted to ¥1,939,726,122.82, reflecting a 13.75% growth from ¥1,705,232,197.42 at the end of 2022[127]. - The company reported a quarterly revenue of ¥298,086,557.49 in Q4 2023, with a net profit of ¥10,142,780.42 for the same quarter[128]. Dividends and Shareholder Information - The company plans to distribute a cash dividend of 0.60 RMB per 10 shares to all shareholders, based on a total of 289,057,018 shares[3]. - The company reported a total shareholding of 653,000 shares for Chairman Wang Ren, with no changes during the period due to marriage transfer[92]. - Director Fang Shengling increased her shareholding by 7,734,700 shares, bringing her total to 7,766,995 shares before her resignation[92]. - The company has no shareholding changes reported for several directors and independent directors, indicating stable governance[92]. Governance and Management - The board of directors has confirmed the accuracy and completeness of the annual report, ensuring no false statements or omissions[15]. - The company has established a complete governance structure, ensuring independence in asset management, personnel, and financial operations[70]. - The company has a diverse board with members holding significant academic and professional backgrounds, including expertise in economics, agriculture, and technology[88][89][90][91]. - The company is actively involved in digital transformation and organizational restructuring, focusing on business model innovation[93]. - The company has appointed several independent directors with extensive experience in various industries, enhancing its governance structure[93]. - The company’s management team includes professionals with backgrounds in finance, engineering, and digital agriculture, indicating a diverse skill set[99]. - The company is committed to enhancing its financial management and risk control through experienced personnel in key positions[98]. Research and Development - The company aims to leverage CRISPR gene editing technology and other molecular biology methods for continuous R&D and technological innovation in the agricultural biotechnology sector[34]. - The company has established a high-throughput screening platform for soil microorganisms and genomic analysis to support the development of microbial agents and bio-fertilizers[34]. - The company is focusing on the integration of traditional fertilizer sales with soil testing and fertilization technology, aiming for improved agricultural efficiency[133]. - The company has a strong focus on research and development, with several ongoing projects in molecular biology and agricultural technology[96]. - The company is actively involved in research and development of beneficial microorganisms and bio-fertilizer formulations to enhance agricultural productivity[170]. - The company is investing CNY 20 million in R&D for new product development, particularly in biodegradable materials[111]. - The company has developed various patented technologies for fertilizer additives, enhancing product performance and meeting environmental regulations[125]. - The company holds 209 domestic authorized patents and 19 PCT international patents, with one major technological achievement recognized as internationally leading[194]. Market Expansion and Sales Strategy - The company is actively expanding its sales team to target previously untapped markets, focusing on both international and domestic business[34]. - The company is actively expanding its international market presence, establishing direct sales channels with foreign BB fertilizer manufacturers and traders[106]. - Hubei Forbon is focusing on expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2024[111]. - The company has established stable partnerships with over 400 fertilizer enterprises globally, enhancing its market presence in East Asia, Southeast Asia, Europe, and North Africa[150]. - The company has a two-tier distribution model through provincial and county-level distributors to enhance market influence and sales volume[106]. - The company’s marketing strategies include participation in exhibitions, seminars, and product promotion events to showcase product effectiveness[106]. Risk Management - The company has outlined potential risks in its operations, emphasizing the importance of investor awareness regarding these risks[16]. - The company faces risks related to high accounts receivable balances due to the cyclical nature of its customers, which may impact cash flow and profitability[45]. - The company is committed to strict accounting policies for bad debt provisions and plans to implement efficient customer management to mitigate risks associated with accounts receivable[45]. - The company is implementing measures to mitigate foreign exchange risks, including shortening quotation cycles and increasing the proportion of direct RMB settlements[58]. Product Development and Innovation - The company has developed a comprehensive range of fertilizer products, including water-soluble fertilizers and microbial fertilizers, to meet diverse customer needs[105]. - The company has successfully developed various value-added fertilizers and soil improvement products, including oxygen-releasing fertilizers and customized fertilizers, aimed at enhancing soil quality and crop yield[161]. - The company is focusing on the development of low-carbon, green, and efficient agricultural additives, aligning with the new development philosophy of "innovation, coordination, green, openness, and sharing"[146]. - The company is leveraging its research platform to develop new products for soil restoration and fertilizer reduction, aiming to enhance agricultural sustainability and food security[161]. - The company is committed to sustainable practices, responding to government initiatives to reduce chemical pesticide usage by 50% by 2030[178]. Strategic Partnerships and Collaborations - The company has established equity cooperation with Kangxin Bio and Xiangyu Bio to introduce microbial agents and biological fertilizers[76]. - The company is collaborating with Professor Chen Sanfeng's team from China Agricultural University on nitrogen-fixing bacteria technology, with significant research results in wheat, corn, and rice[182]. - The company is utilizing partnerships with research institutions to enhance its technological capabilities in agricultural biotechnology[170]. - The company has established long-term partnerships with several universities for collaborative research, further boosting its R&D capabilities[194]. Production Capacity and Operations - The company has a designed production capacity of 23,000 tons per annum for fertilizer anti-caking agents (powder), with a capacity utilization rate of 124.07%[56]. - The company has completed construction of a production line for round granule potassium fertilizer with a designed capacity of 100,000 tons per annum, currently operating at a capacity utilization rate of 28.45%[56]. - The company has a designed production capacity of 90,000 tons per annum for ordinary caramel, with a capacity utilization rate of 62.50%[56]. - The company has a designed production capacity of 4,000 tons per annum for Bacillus thuringiensis, currently operating at a capacity utilization rate of 46.40%[56]. - The company has a designed production capacity of 4,000 tons per annum for Bacillus subtilis, currently operating at a capacity utilization rate of 13.20%[56]. - The company has established three production bases in Hubei, Shandong, and for customized product manufacturing, leveraging its globally leading sand material granulation technology[106]. Digital Transformation - The company is actively involved in digital transformation and organizational restructuring, focusing on business model innovation[93]. - The company has developed a digital water and fertilizer integration system to optimize irrigation and fertilization processes, enhancing agricultural efficiency[198]. - The company has established a soil testing and data analysis service using advanced technologies like Alsys analysis robots and SoilOptix CT scanning vehicles for precise agricultural planning[198]. - The company has implemented a new digital marketing strategy, resulting in a 25% increase in online sales channels[111]. - The company has established the "Tomato Community" e-commerce brand to enhance consumer engagement and accumulate user data for personalized product offerings[183].